Literature DB >> 2754055

Melanocytic nevi in schoolchildren in Queensland.

A Green1, V Siskind, M E Hansen, L Hanson, P Leech.   

Abstract

In a group of 211 schoolchildren in Queensland less than 12 years of age, the mean total melanocytic nevus (mole) count was 28 (median 19), and the mean count for raised nevi was 11 (median 8). The upper aspect of the back and chest were the most commonly affected sites, with the neck being the third. Boys had significantly (p less than 0.01) more melanocytic nevi than girls, and prevalence was highest in children with pale skin and light-colored hair. Nonwhite heritage had a protective effect independent of pigmentary characteristics. Total numbers of nevi on children also were related to maternal tendency to large numbers of moles and to family history of melanoma. The only significant association observed for the presence of large (greater than 5 mm) nevi on children was a family history of melanoma. The children studied come from a general population that has the highest known risk of melanoma. In Australia they have been shown to have the highest prevalence of nevi ever reported in the prepubertal age group. These descriptive data, together with the specific pigmentary and family associations described, extend the known links between benign nevi and malignant melanoma.

Entities:  

Mesh:

Year:  1989        PMID: 2754055     DOI: 10.1016/s0190-9622(89)70131-6

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  9 in total

1.  Nevi and migration within the United States and Canada: a population-based cross-sectional study.

Authors:  L K Dennis; E White; B McKnight; A Kristal; J A Lee; P Odland
Journal:  Cancer Causes Control       Date:  1996-07       Impact factor: 2.506

2.  Effect of hair color and sun sensitivity on nevus counts in white children in Colorado.

Authors:  Jenny Aalborg; Joseph G Morelli; Tim E Byers; Stefan T Mokrohisky; Lori A Crane
Journal:  J Am Acad Dermatol       Date:  2010-06-26       Impact factor: 11.527

3.  Malignant melanoma in childhood: a clinicopathologic study of 13 cases and comparison with Spitz nevi.

Authors:  K A Crotty; S W McCarthy; A A Palmer; A B Ng; J F Thompson; M P Gianoutsos; H M Shaw
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

4.  Sunburn, sun exposure, and sun sensitivity in the Study of Nevi in Children.

Authors:  Jaya M Satagopan; Susan A Oliveria; Arshi Arora; Michael A Marchetti; Irene Orlow; Stephen W Dusza; Martin A Weinstock; Alon Scope; Alan C Geller; Ashfaq A Marghoob; Allan C Halpern
Journal:  Ann Epidemiol       Date:  2015-05-23       Impact factor: 3.797

5.  Childhood melanoma in Australia.

Authors:  W R McWhirter; C Dobson
Journal:  World J Surg       Date:  1995 May-Jun       Impact factor: 3.352

6.  Trajectories of Nevus Development From Age 3 to 16 Years in the Colorado Kids Sun Care Program Cohort.

Authors:  Nancy L Asdigian; Anna E Barón; Joseph G Morelli; Stefan T Mokrohisky; Jenny Aalborg; Robert P Dellavalle; Matthew F Daley; Marianne Berwick; Keith E Muller; Neil F Box; Lori A Crane
Journal:  JAMA Dermatol       Date:  2018-11-01       Impact factor: 10.282

7.  Study of Nevi in Children (SONIC): baseline findings and predictors of nevus count.

Authors:  Susan A Oliveria; Jaya M Satagopan; Alan C Geller; Stephen W Dusza; Martin A Weinstock; Marianne Berwick; Marilyn Bishop; Maureen K Heneghan; Allan C Halpern
Journal:  Am J Epidemiol       Date:  2008-11-10       Impact factor: 4.897

8.  Comparability of naevus counts between and within examiners, and comparison with computer image analysis.

Authors:  J F Aitken; A Green; A Eldridge; L Green; J Pfitzner; D Battistutta; N G Martin
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

9.  Melanocytic naevi and melanoma in survivors of childhood cancer.

Authors:  A Green; P Smith; W McWhirter; P O'Regan; D Battistutta; M E Yarker; K Lape
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.